Does APIXABAN Cause Cutaneous vasculitis? 131 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Cutaneous vasculitis have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
131
Reports of Cutaneous vasculitis with APIXABAN
0.1%
of all APIXABAN reports
5
Deaths
66
Hospitalizations
How Dangerous Is Cutaneous vasculitis From APIXABAN?
Of the 131 reports, 5 (3.8%) resulted in death, 66 (50.4%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
INFLIXIMAB (108)
RITUXIMAB (93)
Which APIXABAN Alternatives Have Lower Cutaneous vasculitis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ